JPRN-UMIN000023606
Completed
未知
Evaluation of risk-reducing salpingo-oophorectomy for patients with BRCA 1/2 mutation - Evaluation of RRSO for patients with BRCA 1/2 mutation
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- hereditary breast and ovarian cancer: HBOC
- Sponsor
- Kindai University Hospital
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •no mutation of BRCA1/2
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Study on risk reducing salpingo-oophorectomy(RRSO) for BRCA1/2 mutation carriershereditary breast and ovarian cancerJPRN-UMIN000005292Cancer Institute Hospital Department of Gynecology, Breast center, Clinical Genetic Oncology200
Recruiting
Not Applicable
Clinical study of risk reducing salpingo-oophorectomy (RRSO) in patients with pathological variants of the BRCA1/2 geneHereditary Breast and Ovarian Cancer, HBOCJPRN-UMIN000042914Sapporo Medical University20
Recruiting
Not Applicable
Establishment of risk-reducing salpingo-oohorectomy for hereditary breast and ovarian syndromeovarian cancer tubal cancerJPRN-UMIN000024515Fujita Health University, Gynecology and Obstetrics5
Completed
Not Applicable
Evaluation of prophylactic salpingectomy on ovarian functioterine bleeding.Irregular menstruation, unspecifiedIRCT2014123118866N4Vice chancellor for research, Tehran University of Medical Sciences40
Completed
Not Applicable
Risk reducing salpingo-oophorectomy RRSO in BRCA1/2 mutation carriers.Hereditary Breast and Ovarian CancerJPRN-UMIN000027999agoya university faculty of Medicine8